Table 1 Comparison of baseline characteristics of (A) the 19 autopsy patients presented in the first part of the study and (B) the admitted patients presenting with or without features of malaria retinopathy in the second part of the study
From: Human cerebral malaria and Plasmodium falciparum genotypes in Malawi
Characteristic | Cerebral Malaria (+/− SMA) | Non-CM (including SMA) | P* |
|---|---|---|---|
| Â | (N = 10) | (N = 9) | Â |
| Â | Median (IQR) | Â | Â |
Age [months] | 24 (18-70) | 25.5 (17-39) | 0.64 |
Time [weeks]†| 13.6 (9.4 - 16.4) | 10 (9-14.3) | 0.49 |
Haematocrit [%] | 18 (14-31) | 29.5 (22-40) | 0.15 |
Parasitaemia [p/ul] | 275,200 (11,399-572,880) | 98,518 (4,716-286,850) | 0.25 |
Characteristic | Retinopathy Positive (N = 69) | Retinopathy Negative (N = 34) | P* |
| Â | Median (IQR) | Â | Â |
Age [months] | 38 (25-56) | 51 (31-67) | 0.19 |
Time [weeks]†| 7.4 (4.3, 12.9) | 10.4 (4.1, 17.4) | 0.44 |
Haematocrit [%] | 22 (18, 27) | 30 (25, 34) | 0.0003 |
Parasitaemia [p/ul] | 101,176 (31,590-366,070) | 70,230 (42,871-211,680) | 0.71 |